Octreotide recalls: lots, NDC and companies
2 FDA recall records mention Octreotide since April 1, 2026. Each covers specific lots from one company. Check yours below.
Check your Octreotide bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Sterility
Teva Pharmaceuticals USA, Inc: Octreotide Acetate for Injectable Suspension
Hazard (FDA): Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
FDAMedicines
Sterility
Teva Pharmaceuticals USA, Inc: Octreotide Acetate for Injectable Suspension and 2 more
Hazard (FDA): Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
FDAMedicines
Atom feed of this list(the 40 newest). Data collected 2026-11-17.